Ftse Mib
34.072,72
0,99%
DAX
19.984,32
0,74%
S&P 500
5.974,92
-1,04%
NASDAQ
19.712,16
-1,54%
Bitcoin
94.531,23
-1,21%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Bionik Laboratories Corporation (CE) (BNKL) Bionik Laboratories Corporation (CE) (BNKL) Notizie

BNKL

Bionik Laboratories (CE) (BNKL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:BNKL
DataOraFonteTitoloSimboloCompagnia
30/06/202322:31Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:BNKLBionik Laboratories Corporation (CE)
21/06/202323:05Edgar (US Regulatory)Annual Report (10-k)USOTC:BNKLBionik Laboratories Corporation (CE)
21/06/202316:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
16/06/202314:56Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
08/02/202314:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BNKLBionik Laboratories Corporation (CE)
07/12/202217:29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:BNKLBionik Laboratories Corporation (CE)
07/12/202217:27Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:BNKLBionik Laboratories Corporation (CE)
04/11/202221:32Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:BNKLBionik Laboratories Corporation (CE)
25/10/202217:28Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:BNKLBionik Laboratories Corporation (CE)
27/05/202219:31Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:BNKLBionik Laboratories Corporation (CE)
01/06/202020:17Edgar (US Regulatory)Specialized Disclosure Report (sd)USOTC:BNKLBionik Laboratories Corporation (CE)
21/02/202023:12Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:BNKLBionik Laboratories Corporation (CE)
13/02/202018:17Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:BNKLBionik Laboratories Corporation (CE)
13/11/201912:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:BNKLBionik Laboratories Corporation (CE)
12/11/201921:58Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:BNKLBionik Laboratories Corporation (CE)
28/10/201915:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:BNKLBionik Laboratories Corporation (CE)
16/09/201923:26Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:BNKLBionik Laboratories Corporation (CE)
18/03/201911:05Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:BNKLBionik Laboratories Corporation (CE)
11/02/201922:21Edgar (US Regulatory)Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement...USOTC:BNKLBionik Laboratories Corporation (CE)
16/10/201823:24Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:BNKLBionik Laboratories Corporation (CE)
17/08/201823:15Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:BNKLBionik Laboratories Corporation (CE)
10/08/201823:11Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:BNKLBionik Laboratories Corporation (CE)
07/08/201823:36Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:BNKLBionik Laboratories Corporation (CE)
15/06/201820:38Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)USOTC:BNKLBionik Laboratories Corporation (CE)
05/10/201723:27Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:BNKLBionik Laboratories Corporation (CE)
05/10/201720:30Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)USOTC:BNKLBionik Laboratories Corporation (CE)
03/08/201723:29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:BNKLBionik Laboratories Corporation (CE)
14/07/201723:29Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:BNKLBionik Laboratories Corporation (CE)
12/07/201722:27Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:BNKLBionik Laboratories Corporation (CE)
30/06/201723:08Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)USOTC:BNKLBionik Laboratories Corporation (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:BNKL

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
SRG
Snam
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
SPM
Saipem
BIT
LDO
Leonardo
BIT
PRY
Prysmian
BIT
TEN
Tenaris
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network